Skip to main content
SpringerLink
Log in

Converting Viral Villains to Cancer Cures

Oncolytic Virotherapy Creeps Closer to the Clinic

  • Emerging Technology
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Reference

  1. Martuza RL, Malick A, Markert JM, et al. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252 (5007): 854–6

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Converting Viral Villains to Cancer Cures. Pharmaceutical & Diagnostic Innovation 3, 8–12 (2005). https://doi.org/10.1007/BF03257012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257012

Keywords

Search

Navigation